Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol.

Saved in:
Bibliographic Details
Title: Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol.
Authors: Diab Casares L; Clinical Microbiology Department, Consorcio Hospital General Universitario de Valencia, Valencia, Comunidad Valenciana, Spain.; Mycobacteria Study Group, Spanish Society of Infectious Diseases and Clinical Microbiology (GEIM-SEIMC), Spain, Spain., Espinosa Pereiro J; Mycobacteria Study Group, Spanish Society of Infectious Diseases and Clinical Microbiology (GEIM-SEIMC), Spain, Spain.; Infectious Diseases Department, Hospital Universitario Vall d'Hebron, Barcelona, Cataluña, Spain.; Networked Biomedical Research Center for Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Tórtola Fernández MT; Mycobacteria Study Group, Spanish Society of Infectious Diseases and Clinical Microbiology (GEIM-SEIMC), Spain, Spain.; Networked Biomedical Research Center for Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Microbiology Department, Autonomous University of Barcelona, Medicine Department, Campus Hospital Universitario Vall d'Hebron, Barcelona, Cataluña, Spain., Casas García X; Respiratory Department, Serveis Clinics SAU, Barcelona, Cataluña, Spain.; Respiratory Infections Working Group of the Catalan Society of Respiratory Medicine (SOCAP), Cataluña, Cataluña., Millet JP; Epidemiology, Public Health Agency of Catalonia, Barcelona, Cataluña, Spain.; CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain., Pomar Solchaga V; Infectious Diseases Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Cataluña, Spain., Navas Elorza E; Infectious Diseases Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Troya García J; Department of Internal Medicine, Hospital Universitario Infanta Leonor, Madrid, Spain., Díaz de Santiago A; Department of Internal Medicine, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain., Luque Márquez R; Infectious Diseases Department, Hospital Universitario Virgen del Rocío, Sevilla, Andalucía, Spain., Medina Gallardo JF; Medical-Surgical Unit for Respiratory Diseases (UMQER), Hospital Universitario Virgen del Rocío, Sevilla, Andalucía, Spain.; Integrated Research Program on Tuberculosis and Nontuberculous Mycobacteria (PII-TB&MNT), Spanish Society of Respiratory Medicine and Thoracic Surgery (SEPAR), Spain., González Galán V; Mycobacteria Study Group, Spanish Society of Infectious Diseases and Clinical Microbiology (GEIM-SEIMC), Spain, Spain.; Clinical Unit of Infectious Diseases, Microbiology and Clinical Parasitology (UCEIMP), Hospital Universitario Virgen del Rocío, Sevilla, Spain.; Seville Institute of Biomedicine, Sevilla, Andalucía, Spain., Montero Alonso M; Infectious Diseases Department, Hospital Universitario y Politecnico La Fe, Valencia, Spain., Gil Brusola A; Microbiology Department, Hospital Universitario y Politecnico La Fe, Valencia, Spain., Rabuñal Rey R; Mycobacteria Study Group, Spanish Society of Infectious Diseases and Clinical Microbiology (GEIM-SEIMC), Spain, Spain.; Department of Internal Medicine, Hospital Universitario Lucus Augusti, Lugo, Spain., Anibarro García L; Tuberculosis Unit, Infectious Diseases, Internal Medicine Department, Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Galicia, Spain.; Immunology Research Group, Research Institute, Sanitaria Galicia Sur, Santiago de Compostela, Spain., Sanz Herrero F; Respiratory Department, Consorcio Hospital General Universitario de Valencia, Valencia, Comunidad Valenciana, Spain., Guna Serrano R; Clinical Microbiology Department, Consorcio Hospital General Universitario de Valencia, Valencia, Comunidad Valenciana, Spain.; Mycobacteria Study Group, Spanish Society of Infectious Diseases and Clinical Microbiology (GEIM-SEIMC), Spain, Spain.; Clinical Microbiology Department, Faculty of Medicine, University of Valencia, Valencia, Spain., Garrigó Fullola M; Clinical Microbiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Sant Pau Biomedical Research Institute, Barcelona, Cataluña, Spain.; Department of Genetics and Microbiology, Autonomous University of Barcelona, Barcelona, Cataluña, Spain., Tato Díez M; Clinical Microbiology Department, Hospital Universitario Ramon y Cajal, Madrid, Madrid, Spain., Talavan Zanón T; Clinical Microbiology Department, Hospital Universitario Infanta Leonor, Madrid, Spain., Portero MF; Clinical Microbiology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain., Alonso García P; Clinical Microbiology Department, Hospital Universitario Lucus Augusti, Lugo, Galicia, Spain., Saez López AM; Clinical Microbiology Department, Hospital Provincial de Pontevedra, Pontevedra, Galicia, Spain., Aznar ML; Mycobacteria Study Group, Spanish Society of Infectious Diseases and Clinical Microbiology (GEIM-SEIMC), Spain, Spain.; Infectious Diseases Department, Hospital Universitario Vall d'Hebron, Barcelona, Cataluña, Spain.; Networked Biomedical Research Center for Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Martínez Campreciós J; Infectious Diseases Department, Hospital Universitario Vall d'Hebron, Barcelona, Cataluña, Spain.; Networked Biomedical Research Center for Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Saborit N; Infectious Diseases Department, Hospital Universitario Vall d'Hebron, Barcelona, Cataluña, Spain., Sánchez Montalvá A; Mycobacteria Study Group, Spanish Society of Infectious Diseases and Clinical Microbiology (GEIM-SEIMC), Spain, Spain adrian.sanchez.montalva@gmail.com.; Infectious Diseases Department, Hospital Universitario Vall d'Hebron, Barcelona, Cataluña, Spain.; Networked Biomedical Research Center for Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Source: BMJ open respiratory research [BMJ Open Respir Res] 2025 Dec 07; Vol. 12 (1). Date of Electronic Publication: 2025 Dec 07.
Publication Type: Journal Article; Clinical Trial Protocol
Journal Info: Publisher: BMJ Publishing Group Ltd & British Thoracic Society Country of Publication: England NLM ID: 101638061 Publication Model: Electronic Cited Medium: Internet ISSN: 2052-4439 (Electronic) Linking ISSN: 20524439 NLM ISO Abbreviation: BMJ Open Respir Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2052-4439
DOI:10.1136/bmjresp-2024-002475